pharmaphorum1h
FDA rethinking block on compounding of Lilly's obesity drug
The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...
Diversified Exposure To The Weight Loss Drug Market
The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...
The Local5d
French healthcare system won’t pay for new anti-obesity drug
New-generation anti-obesity drug Wegovy, made by the same company ... with their GP’s approval. The ANSM said in a press release that the use of this type of drug as a treatment for obesity ...
3 No-Brainer Growth Stocks to Buy in October
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Outsourcing-pharma3d
Antag Therapeutics gets FDA clearance to start clinical trials with new obesity drug
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
tyla6d
What Ozempic actually does to your body as numerous celebrities speak out about drug
More severe side effects can include pancreatitis, vision changes, allergic reactions, fatigue or dizziness, gallstones, ...
CNN5d
Your employer may start covering weight-loss drugs soon
The chances of your employer covering an anti-obesity drug depends on its size — bigger organizations are much more likely to offer the benefit than smaller ones. Workers are eligible for the ...
Medicare coverage of obesity drugs could raise federal spending by $35B through 2034 - CBO
Medicare coverage of weight loss drugs, if authorized, would increase federal spending by about $35B from 2026 to 2034, ...
Medicare coverage of weight loss drugs would cost $35B: CBO
Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...